2022 Annual Meeting | C11 - Neurology Update

Date Saturday 04/02/22

Time 07:00 AM - 04:00 PM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Full-Day Course

Director(s) Adam Quick, MD

Topic(s) General Neurology, Aging, Dementia, and Behavioral Neurology, Cerebrovascular Disease and Interventional Neurology, Epilepsy/Clinical Neurophysiology (EEG), Headache, Infectious Disease, Movement Disorders, Multiple Sclerosis, Neuromuscular and Clinical Neurophysiology (EMG), Neuro-oncology, Sleep

Learning Objectives Neurology is a rapidly evolving field of medicine that has differentiated into numerous subspecialties. It can be an enormous challenge for many neurologists to stay current on recent diagnostic and therapeutic advancements. Participants in the course should learn about the most important developments in each subspecialty of neurology from the past year or two and become familiar with how to apply these changes to clinical practice.

CME Available 7.50 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Didactic

Program Materials Program Evaluations

Event Timeline
07:00 AM - 07:10 AM PDT	Introduction	Introduction Adam Quick, MD
07:00 AM - 04:00 PM PDT	Speaker	walk in slides Adam Quick, MD
07:10 AM - 07:55 AM PDT	Speaker	Update in Dementia Philip W. Tipton, MD
07:55 AM - 08:40 AM PDT	Speaker	Update in Neurological Infectious Disease Kenneth L. Tyler, MD, FAAN
08:40 AM - 09:25 AM PDT	Speaker	Update in Movement Disorders Sarah Pirio Richardson, MD, FAAN
09:25 AM - 09:40 AM PDT	Break	Break
09:40 AM - 10:25 AM PDT	Speaker	Update in Neuromuscular Disease Kelly G. Gwathmey, MD
10:25 AM - 11:10 AM PDT	Speaker	Update in Multiple Sclerosis Michelle Fabian, MD, FAAN
11:10 AM - 12:10 PM PDT	Break	Lunch
12:15 PM - 01:00 PM PDT	Speaker	Update in Sleep Rachel Marie E. Salas, MD, MEd, FAAN
01:00 PM - 01:45 PM PDT	Speaker	Update in Epilepsy Gregory K. Bergey, MD, FAAN
01:45 PM - 02:30 PM PDT	Speaker	Update in Neuro-oncology Roy E. Strowd III, MD, FAAN
02:30 PM - 02:40 PM PDT	Break	Break
02:40 PM - 03:20 PM PDT	Speaker	Update in Stroke David L. Tirschwell, MD, FAAN
03:20 PM - 04:00 PM PDT	Speaker	Update in Headache Christopher J. Boes, MD, FAAN

Faculty Disclosures
Adam Quick, MD	The institution of Dr. Quick has received research support from NINDS. The institution of Dr. Quick has received research support from NEALS.
Kenneth L. Tyler, MD, FAAN	Dr. Tyler has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Protagonist Therapeutics, Newark CA. Dr. Tyler has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Neurological Association/Wiley. Dr. Tyler has received intellectual property interests from a discovery or technology relating to health care. Dr. Tyler has received publishing royalties from a publication relating to health care. Dr. Tyler has a non-compensated relationship as a Director (ex officio) with American Neurological association that is relevant to AAN interests or activities. Dr. Tyler has a non-compensated relationship as a Director with International Society for Neurovirology that is relevant to AAN interests or activities.
Rachel Marie E. Salas, MD, MEd, FAAN	Dr. Salas has received personal compensation for serving as an employee of ScholarRx. Dr. Salas has received personal compensation for serving as an employee of HMPGlobal. Dr. Salas has received personal compensation for serving as an employee of Idorsia. Dr. Salas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Learning Network. Dr. Salas has received publishing royalties from a publication relating to health care.
Roy E. Strowd III, MD, FAAN	Dr. Strowd has received personal compensation for serving as an employee of Kaplan. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical, Inc. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Strowd has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. The institution of Dr. Strowd has received research support from Southeastern Brain Tumor Foundation. The institution of Dr. Strowd has received research support from Jazz Pharmaceuticals. The institution of Dr. Strowd has received research support from National Institutes of Health. The institution of Dr. Strowd has received research support from Alpha Omega Alpha. The institution of Dr. Strowd has received research support from American Board of Psychiatry and Neurology. Dr. Strowd has received publishing royalties from a publication relating to health care. Dr. Strowd has received publishing royalties from a publication relating to health care.
Gregory K. Bergey, MD, FAAN	Dr. Bergey has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurotherapeutics.
Michelle Fabian, MD, FAAN	Dr. Fabian has nothing to disclose.
Christopher J. Boes, MD, FAAN	Dr. Boes has nothing to disclose.
Sarah Pirio Richardson, MD, FAAN	The institution of Dr. Pirio Richardson has received research support from NIH. The institution of Dr. Pirio Richardson has received research support from DOD. The institution of Dr. Pirio Richardson has received research support from Pharma 2B. The institution of Dr. Pirio Richardson has received research support from AEON. The institution of Dr. Pirio Richardson has received research support from ADDEX.
Kelly G. Gwathmey, MD	Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strongbridge. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Gwathmey has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals.
Philip W. Tipton, MD	Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Alzheimer's Tennessee. Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Charlotte County Medical Society, Inc.
David L. Tirschwell, MD, FAAN	Dr. Tirschwell has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CARMAT. Dr. Tirschwell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. The institution of Dr. Tirschwell has received research support from Abbott. The institution of Dr. Tirschwell has received research support from NIH.